1. ⁹⁰Y/¹⁷⁷Lu-DOTATATE therapy: survival of the fittest?

   • Boudewijn Brans
   • Felix M. Mottaghy
   • Alfons Kessels

   Editorial Commentary Open access 14 July 2011 Pages: 1785 - 1787

2. Clinical results of radionuclide therapy of neuroendocrine tumours with ⁹⁰Y-DOTATATE and tandem ⁹⁰Y/¹⁷⁷Lu-DOTATATE: which is a better therapy option?

   • Jolanta Kunikowska
   • Leszek Królicki
   • Dariusz Pawlak

   Original Article Open access 07 May 2011 Pages: 1788 - 1797

   

3. Combined therapy with ¹³¹I and retinoic acid in Korean patients with radioiodine-refractory papillary thyroid cancer

   • So Won Oh
   • Seung-hwan Moon
   • June-Key Chung

   Original Article 23 June 2011 Pages: 1798 - 1805

   

4. Imaging tumor endothelial marker 8 using an ¹⁸F-labeled peptide

   • Qimeng Quan
   • Min Yang
   • Xiaoyuan Chen

   Original Article 04 August 2011 Pages: 1806 - 1815

   

5. Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by ¹⁸F-FAZA PET/CT utilizing multimodality fusion techniques

   • Rita Garcia-Parra
   • David Wood
   • Morand Piert

   Original Article 16 July 2011 Pages: 1816 - 1823

   

6. Additional value of 16α-[¹⁸F]fluoro-17β-oestradiol PET for differential diagnosis between uterine sarcoma and leiomyoma in patients with positive or equivocal findings on [¹⁸F]fluorodeoxyglucose PET

   • Yoshio Yoshida
   • Yasushi Kiyono
   • Fumikazu Kotsuji

   Original Article 08 June 2011 Pages: 1824 - 1831

   

7. ^99mTc-HYNIC-spermine for imaging polyamine transport system-positive tumours: preclinical evaluation

   • Sabrina Pesnel
   • Yves Guminski
   • Alain Le Pape

   Original Article 10 June 2011 Pages: 1832 - 1841

   

8. Do androgens control the uptake of ¹⁸F-FDG, ¹¹C-choline and ¹¹C-acetate in human prostate cancer cell lines?

   • Kimy M. Emonds
   • Johannes V. Swinnen
   • Felix M. Mottaghy

   Original Article 06 July 2011 Pages: 1842 - 1853

   

9. Total ¹⁸F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour

   • Helle-Brit Fiebrich
   • Johan R. de Jong
   • Elisabeth G.E. de Vries

   Original Article Open access 23 June 2011 Pages: 1854 - 1861

   

10. Diagnosis and dosimetry in differentiated thyroid carcinoma using ¹²⁴I PET: comparison of PET/MRI vs PET/CT of the neck

    • James Nagarajah
    • Walter Jentzen
    • Alexander Stahl

    Original Article 08 July 2011 Pages: 1862 - 1868

    

11. Clinical significance of 2-[¹⁸F]fluoro-2-deoxy-d-glucose positron emission tomography for the assessment of ¹³¹I-metaiodobenzylguanidine therapy in malignant phaeochromocytoma

    • Azusa Nakazawa
    • Tetsuya Higuchi
    • Keigo Endo

    Original Article 06 July 2011 Pages: 1869 - 1875

    

12. Dynamic ¹¹C-methionine PET analysis has an additional value for differentiating malignant tumors from granulomas: an experimental study using small animal PET

    • Songji Zhao
    • Yuji Kuge
    • Nagara Tamaki

    Original Article 06 July 2011 Pages: 1876 - 1886

    

13. Attenuation correction for myocardial perfusion SPECT imaging: still a controversial issue

    • Alberto Cuocolo

    Editorial Commentary 27 August 2011 Pages: 1887 - 1889

14. Impact of attenuation correction and gated acquisition in SPECT myocardial perfusion imaging: results of the multicentre SPAG (SPECT Attenuation Correction vs Gated) study

    • Dario Genovesi
    • Assuero Giorgetti
    • Paolo Marzullo

    Original Article 09 June 2011 Pages: 1890 - 1898

    

15. Impaired cardiac sympathetic innervation in symptomatic patients with long QT syndrome

    • Peter Kies
    • Matthias Paul
    • Eric Schulze-Bahr

    Original Article 21 June 2011 Pages: 1899 - 1907

    

16. Comparison of the myocardial blood flow response to regadenoson and dipyridamole: a quantitative analysis in patients referred for clinical ⁸²Rb myocardial perfusion PET

    • Behnaz Goudarzi
    • Kenji Fukushima
    • Frank M. Bengel

    Original Article 09 June 2011 Pages: 1908 - 1916

    

17. Integrated SPECT/CT for assessment of haemodynamically significant coronary artery lesions in patients with acute coronary syndrome

    • Shmuel Rispler
    • Doron Aronson
    • Zohar Keidar

    Original Article 18 June 2011 Pages: 1917 - 1925

    

18. PET molecular imaging in stem cell therapy for neurological diseases

    • Jiachuan Wang
    • Mei Tian
    • Hong Zhang

    Review Article 23 June 2011 Pages: 1926 - 1938

    

19. Evolving role of FDG PET imaging in assessing joint disorders: a systematic review

    • Kathleen Carey
    • Babak Saboury
    • Abass Alavi

    Review Article 14 July 2011 Pages: 1939 - 1955

    

20. [¹⁸F]Fluoride and [¹⁸F]fluorodeoxyglucose PET/CT in myositis ossificans of the forearm

    • Kanhaiyalal Agrawal
    • Anish Bhattacharya
    • Ramesh Kumar Sen

    Image of the Month 30 March 2011 Pages: 1956 - 1956

    

21. Abnormal pelvic uptake on post-therapeutic radioiodine (¹³¹I) whole-body scan

    • Desiree Deandreis
    • Jean Lumbroso
    • Sophie Leboulleux

    Image of the Month 02 April 2011 Pages: 1957 - 1957

    

22. The EANM Physics Committee celebrates its first 5 years

    Society Communications 08 September 2011 Pages: 1958 - 1959